on normal hemopoietic stem cells. [1][2][3] The treatment of bone marrow (BM) and mobilized peripheral blood stem cell (PBSC) with Campath-1, has proved to be an effective Campath-1G is a CD52 (rat IgG2b) moAb used in bone marrow transplantation (BMT) to prevent graft-versusmethod for preventing graft-versus-host disease (GVHD). [4] [5] [6] [7] Exposing BM or PBSC cells to Campath-1G host disease (GVHD) by the elimination of T cells via antibody-dependent cell cytotoxicity (ADCC) in vivo.
iesis, we undertook the study of the in vitro effect of Campath-1G-treated NK cells on the regulation of
Delayed platelet engraftment is a serious complication in patients undergoing bone marrow transplantation (BMT) or megakaryocytopoiesis. Early burst-forming BFU-MK and late colony-forming CFU-MK were grown from aggressive chemotherapy for cancer treatment resulting in an unpredictable period of protracted thrombocytopenia and 2 × 10 5 peripheral blood non-adherent mononuclear cells (NAMC) in plasma clots in the presence of aplastic bleeding episodes. The production of platelets is thought to be regulated by multi-lineage and lineage-specific (ie canine plasma (PICS-J) which was used as megakaryocyte colony-stimulating factor (MK-CSF). The first step thrombopoietin) growth factors which stimulate megakaryocyte (MK) proliferation and maturation. [10] [11] [12] [13] It has been in elucidating this series of events was to investigate the direct influence of NK cells on megakaryocytopoiesis.
previously demonstrated that the regulation of MK development within the BM is multi-factorial and involves the Co-culturing NK cells (Ͼ85% CD16 + ) with autologous NAMC at a ratio of 1:1 resulted in a significant increase interaction of both stroma and immune effector cells. [14] [15] [16] [17] [18] T cells and soluble T cell factors stimulate megakaryocytic in the proliferation of CFU-MK and BFU-MK over NAMC cultured alone. This effect was further enhanced development. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] Activated lymphocytes produce cytokines that suppport megakaryocyte proliferation and matuupon exposure of NK to Campath-1G (0.1-3 g/ml). To investigate the possible influence of soluble factors ration. [19] [20] [21] [22] [23] [24] Conditioned medium (CM) from spleen cells or blood lymphocytes stimulated with lectins and PHAreleased from NK cells treated with Campath-1G on MK maturation, conditioned medium (CM) derived activated T cells have been shown to stimulate the proliferation of MK progenitors and support MK colony formfrom Campath-1G-treated-enriched populations of NK cells was found to enhance MK progenitor growth. Our ation. [19] [20] [21] [22] 25, 26 We have previously demonstrated that Campath-1G-treated T lymphocytes or purified CD4
+ T cells data demonstrate that resting and Campath-1G-treated NK may be involved in the immunomodulation of significantly enhance the number of early burst-forming units (BFU-MK) and late colony-forming units (CFU-MK) megakaryocytopoiesis. Keywords: natural killer cells; Campath-1G; megakaryoderived from BM-non adherent mononuclear cells. Furthermore, CM from Campath-1G-treated T cells and CD4 + T cytopoiesis cells contained soluble factors which potentiated megakaryocytic growth. 27 Natural killer (NK) cells are a subpopulation of lymphoCampath-1, a rat anti-human monoclonal antibody (moAb), cytes which are distinct from T and B cells and can be recognizes the CD52 cell surface antigen, which is amply identified by CD3⑀ − /CD16 + and/or CD56 + surface markexpressed on the surface of a majority of normal and maligers. [28] [29] [30] In addition, activated NK cells have been shown nant human lymphocytes, but is most probably not present to produce cytokines and growth factors, including granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3), that stimulate myeloid and 27 as well as NK cells and ity units/ml which were equivalent to 1700 pg/ml of human Mpl-ligand. PICS-J contains high levels of active Mpl influences NK cell function. 41 Our goal in the present study was to evaluate the effect of Campath-1G-treated NK cells ligand. 44 MK cultures were incubated at 37°C in humidified air containing 5% CO 2 for 12 days. on megakaryocytopoiesis.
Identification of MK colonies

Materials and methods
MK colonies were identified by indirect immunofluorescence using a rabbit moAb highly specific to human platelet Separation of NK cells glycoproteins. 45 BFU-MK and CFU-MK colonies were Peripheral blood (PB) samples were obtained from healthy counted as previously described. 27 Results were scored as adult donors after receiving informed consent. Monothe mean number of colonies counted in duplicate or triplinuclear cells (MC) were separated from buffy coats by cate assays. Calculation of MK colony growth was as folFicoll-Hypaque (Pharmacia, Uppsala, Sweden) centrifuglows: ation and the cells were resuspended in RPMI 1640 CFU-MK or BFU-MK colony growth index = (Biological Industries, Kibbutz Beit Haemek, Israel) con-MK colonies in co-cultures taining 10% heat-inactivated fetal calf serum (FCS) (Gibco, MK colonies in NAMC fraction alone Grand Island, NY, USA), 1 mm l-glutamine, and 1% penicillin-streptomycin (Biological Industries) (complete The number of MK colonies resulting from the NAMC media). Monocytes were depleted by adherence to plastic fraction alone has a growth index of 1.00. The actual numtissue culture flasks for 2 h. The resulting cells were passed ber of colonies counted was 29.7 ± 4.8 CFU-MK (n = 14) through a nylon wool column for the depletion of B cells and 2.4 ± 0.4 BFU-MK (n = 7). and the cells were centrifuged through a discontinuous Percoll (Pharmacia) gradient (30% over 40%) to isolate the Preparation of conditioned media low buoyant large granular lymphocytes (LGLs). NK cells were negatively selected from LGLs by magnetic bead Campath-1G was incubated with cells at a concentration of depletion. Briefly, LGLs were incubated with purified anti-0.3-10 g/10 6 cells per ml for 30 min at room temperature CD3, CD4, CD5, CD14 and CD19 moAbs (kindly provided in complete medium. YTS, a control isotype antibody by Becton Dickinson Immunocytometry Systems, Santa (IgG2b, rat anti-mouse L3T4 (CD4), clone 191.1.2) which Clara, CA, USA). The cells were washed to remove excess has no binding affinity for CD52 was incubated with cells moAb and were then added to a solution of magnetic beads at 0.3 g/10 6 cells per ml under the above conditions and (sheep anti-mouse IgG; Dynal, Oslo, Norway). The cells was used as a control. These moAbs were kindly provided were applied to a magnet and the negatively selected cell by Dr H Waldmann and Dr G Hale, Cambridge, UK. Folpopulation was stained with a fluorescently-labeled moAb lowing Campath treatment, the cells were washed to to CD16, a low affinity type III Fc receptor found on Ͼ90% remove the moAb and were incubated for an additional 24 of NK cells. 42 The resulting cells were found to be approxih at 37°C in the presence or absence of interleukin-2 (ILmately 85% CD16 + CD3 − by FACS analysis. 2, 600 IU/ml) (Eurocetus, Amsterdam, The Netherlands) in IMDM containing 10% AB serum. Supernatants were collected and stored at −20°C. Untreated cells were incu-MK cultures bated under identical conditions and the resulting supernatants served as controls. Viability following Campath or MK colonies were grown in plasma clots according to the control antibody treatment was Ͼ90% in all experiments. method of Mazur and South. 43 Briefly, MK progenitors Cytokine activity in the supernatants was tested in an MK were isolated from PB or BM by Ficoll-Hypaque gradient colony assay. The assays were performed as previously followed by overnight incubation in tissue culture flasks described using CM in place of IMDM. at 37°C in Iscove's modified Dulbecco's medium (IMDM) (Biological Industries) containing 10% heat inactivated normal human AB serum. PB or BM derived non-adherent FACS analysis mononuclear cells (NAMC) were seeded in a final volume of 0.33 ml containing 2 × 10 5 cells in IMDM supplemented Staining was performed under conditions as previously described. 28 Briefly, FITC and PE-conjugated moAbs with 0.9% bovine serum albumin (BSA) (Biological Industries), and CaCl 2 (5 mm). Human AB plasma was against CD16, CD56 and CD3 cell surface markers as well as IgG isotype control (Becton Dickinson, Santa Clara, CA, added (15% of the final volume) for clot formation. All MK cultures were grown in the presence of MK colony-USA) were added to 1 × 10 6 cells and incubated for 30 min at 4°C. Cells were stained with Campath-1G at 1 stimulating factor which was raised in irradiated aplastic beagles (PICS-J), prepared according to Mazur and South, 43 g/1 × 10 6 cells followed by goat anti-rat FITC. Quantit-ation of fluorescence was performed using a FACStar Plus or a FACScan (Becton Dickinson).
Quantitation of cytokines in conditioned medium
Levels of IL-3 (sensitivity Ͻ40 pg/ml) and IL-6 (sensitivity 3 pg/ml) were measured by radioimmunoassay (RIA). Kits were purchased from Advanced Magnetics (Cambridge, MA, USA). GM-CSF (normal range 60 pg/ml) was tested by ELISA (R&D Systems, Minneapolis, MN, USA) as previously described. [46] [47] [48] Neutralizing antibodies to rhGM-CSF (equivalent to 20 ng neutralizing activity) and rherythropoietin (EPO) (equivalent to 100 units neutralizing activity) were purchased from Genzyme (Cambridge, MA, USA). 44 
Statistical analysis
Results are expressed as the mean ± standard error (s.e.). Statistical significance was determined using a Student's two-tailed t-test. For statistical analysis of cytotoxicity assays significance was estimated using the paired t-test. Values of P Ͻ 0.05 were considered statistically significant. CD56 antigen is present on Ͼ95% of NK cells. 49 Gating
Results
Binding of Campath-1G to NK cells
Preceding histogram analysis, gating was performed on the CD56 + popuwas performed on the CD56 + cells and the binding of Camlation.
path-1G to the NK cell population is shown in Figure 1b while the irrelevant moAb, YTS, bound negligibly Table 1 Effect of conditioned media (CM) derived from an enriched ( Figure 1a) . MK growth resulted from NK cells cultured alone.
c Prepared from 1 × 10 6 cells/ml. 
Table 2
The effect of neutralizing antibodies on rh-GM-CSF and rh-erythropoietin (EPO) in the megakaryocyte stimulation activity of conditioned medium (CM) and 107.0 ± 63.3% BFU-MK at NK:NAMC ratios of 1:1 kines were found. Neutralizing antibodies to erythropoietin, GM-CSF or the combination of both had no effect on the and 1:2 respectively, were found. activity of these supernatants ( Table 2) .
Effect of conditioned medium derived from enriched populations of NK cells treated with Campath-1G on MK Discussion colony growth
Conditioned media (CM) derived from enriched popuProlonged thrombocytopenia and bleeding is one of the major complications in patients following BMT. 10, 47 Immulations of NK cells incubated with Campath-1G were tested for MK colony stimulation. Colony-stimulating activity of nocompetent cells including T cells and NK cells have been previously shown to regulate megakaryocyte growth and CM was tested on BM-derived NAMC (2 × 10 5 cells/well) cultured in the presence and absence of PICS-J. In the maturation. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] 39, 43 Campath-1G is a T lymphocytespecific moAb that is routinely employed to reduce GVHD absence of PICS-J negligible numbers of MK colonies were observed. None of the CM significantly stimulated MK in allogeneic BMT. [1] [2] [3] [4] [5] [6] [7] [8] [9] We have previously demonstrated that Campath-1G-treated lymphocytes or purified CD4
+ T growth more than control medium. However, in the presence of PICS-J, which contains thrombopoietin, CM cells significantly enhanced the number of NAMC-derived BFU-MK and CFU-MK and that CM from Campath-1G-derived from Campath-1G-treated NK cells significantly augments BFU-MK and CFU-MK (Table 1) . The stimutreated T lymphocytes potentiates megakaryocytic growth. 27 In this study, we investigated whether NK cells latory effect of CM from Campath-treated cells on both CFU-MK and BFU-MK growth was significantly stronger treated in vitro with Campath-1G similarly regulate megakaryocytopoiesis. Campath-1G was used at concentrations than that of CM from non-treated cells. NK cells treated by the YTS control moAb did not significantly affect CFUsimilar to those which are used to purge T cells from human bone marrow and G-CSF-mobilized peripheral blood stem MK or BFU-MK growth (Table 1) . When these supernatants were analyzed for the presence of IL-3, IL-6 (RIA) cells prior to transplantation. By co-culturing NK cells with NAMC at a ratio of 1:1, and GM-CSF (ELISA), no detectable levels of these cyto-colony growth. CM derived from enriched populations of NK cells treated with Campath-1G had a highly stimulatory effect on CFU-MK as well as BFU-MK. The precise nature of MK colony-stimulating activity in the CM of NK cells remains to be defined and it would be of interest to check for the presence of Mpl ligand in these supernatants. NK cell stimulatory effect on megakaryocytopoiesis may be either direct or indirect via accessory cell populations as was previously observed for the aplastic canine plasma which strongly stimulated MK colonies from NAMC but had limited effect on purified CD34 + cells.
56
Soluble factors released by activated NK cells have been shown to influence human hematopoiesis as well as megakaryocytopoiesis. 23, [31] [32] [33] [34] [35] [36] [37] [38] The MK colony-stimulating activity found in the CM of Campath-treated cells may thus act in concert with cytokines present in PICS-J, including Mpl ligand. 44 Combinations of cytokines have been demonstrated to be more effective in stimulating megakaryocytopoiesis than a single cytokine as a single cytokine may trigger the MK progenitors into a more active phase of cell cycle by activating additional cytokine receptors possessed by these MK progenitors. 55 In addition, this could increase the sensitivity to other cytokines or activate previously unresponsive subpopulations of MK progenitors. 55 The enhancement of CFU-MK by Campath-1G-treated NK cells may therefore involve a stage-specific recruitment of quiescent, but committed CFU-MK into actively dividing cells by cytokines produced by the activated NK cells. The exact nature of the NK cell-derived MK potentiator is not clear, but its activity requires the presence of PICS-J which contains Mpl ligand, as we have previously demonstrated. 44 Very little is known about regulation of cytokine production in human NK cells. We have previously demonstrated that stimulation of NK cells via both the IL-2R␤ or the CD2 receptor markedly augmented GM-CSF production and that the molecular mechanisms underlying NK cell GM-CSF production are dependent in part on differential surface receptor activation. 31 It is very possible that mechanism is yet to be defined.
it was found that NK cells significantly increase CFU-MK and BFU-MK growth. Our results confirm the work of
